MOJDEH HEIDARI: Open Payments
NPI 1306300397 · WEST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,165 in 134 payments from 18 companies in 2025. Trend: 2023 $4,618 · 2024 $3,171 · 2025 $3,165
Food & beverage: $3,165
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $1,020 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $635 |
| Vanda Pharmaceuticals Inc. | 13 | $318 |
| Otsuka America Pharmaceutical, Inc. | 11 | $259 |
| Janssen Pharmaceuticals, Inc | 7 | $177 |
| E.R. Squibb & Sons, L.L.C. | 5 | $117 |
| Lundbeck LLC | 4 | $79 |
| PFIZER INC. | 3 | $69 |
| Luye Pharma (USA) Ltd. | 3 | $68 |
| Alkermes, Inc. | 4 | $65 |
Products named: CAPLYTA, VRAYLAR, REXULTI, QULIPTA, FANAPT, SPRAVATO, COBENFY, HETLIOZ.
Industry payments across CT — which companies pay providers there.
